Chinese Women Entrepreneur Zhong Huijuan becomes Asia’s Wealthiest Woman after IPO
China-based woman entrepreneur, Zhong Huijuan, founder of Hansoh Pharmaceutical Group, has become Asia’s wealthiest self-made woman
Opinions expressed by Entrepreneur contributors are their own.
You're reading Entrepreneur Asia Pacific, an international franchise of Entrepreneur Media.
China-based woman entrepreneur, Zhong Huijuan, 58, has become Asia’s wealthiest self-made woman, after her drug making company Hansoh Pharmaceutical Group’s stock surged 37% in its first day of trading in Hong Kong stock exchange on 14 June. She now owns US$10.5 billion fortune, trailing just one rank behind Yang Huiyan, co-chairman of Country Garden Holdings, whose fortune is worth US$22.2 billion, according to Bloomberg Billionaire Index. Zhong founded Hansoh in 1995. The company is into research and development, and production of psychotropic drugs for six major therapeutic areas: oncology, central nervous system diseases, anti-infectives, diabetes, gastrointestinal, and cardiovascular. According to Bloomberg, the drugmaker gets almost half of its revenue from cancer treatments. Zhong completed her graduation from China-based Jiangsu Normal University in 1982 and taught chemistry at Yan’an middle school in Lianyungang in the early 1990s. She is married to Sun Piaoyang, who owns pharma a firm, Jiangsu Hengrui Medicine.
China-based woman entrepreneur, Zhong Huijuan, 58, has become Asia’s wealthiest self-made woman, after her drug making company Hansoh Pharmaceutical Group’s stock surged 37% in its first day of trading in Hong Kong stock exchange on 14 June. She now owns US$10.5 billion fortune, trailing just one rank behind Yang Huiyan, co-chairman of Country Garden Holdings, whose fortune is worth US$22.2 billion, according to Bloomberg Billionaire Index. Zhong founded Hansoh in 1995. The company is into research and development, and production of psychotropic drugs for six major therapeutic areas: oncology, central nervous system diseases, anti-infectives, diabetes, gastrointestinal, and cardiovascular. According to Bloomberg, the drugmaker gets almost half of its revenue from cancer treatments. Zhong completed her graduation from China-based Jiangsu Normal University in 1982 and taught chemistry at Yan’an middle school in Lianyungang in the early 1990s. She is married to Sun Piaoyang, who owns pharma a firm, Jiangsu Hengrui Medicine.
